Day: December 28, 2021

SBA Group company Utenos Trikotažas and the State Investment Management Agency (VIVA), which manages the Business Assistance Fund, have signed a financing agreement worth EUR 2.8 million. The fund will purchase the company’s bonds for EUR 2.3 million and will provide another EUR 500 thousand in the form of a loan. The financing is for a period of 6 years. “Recently, we have experienced positive changes in the textile export markets – contract manufacturing is growing, and Utenos Trikotažas is working at full capacity. However, like most industrial sectors we are challenged by the effect of the cost of raw materials, labour and energy costs on our performance. The ongoing global pandemic inevitably has its effects too. The agreement with VIVA will help ensure the sustainable development and expansion of the company,” says Petras Jašinskas,...

PRESS RELEASE: A major Governmental Entity in Europe chooses PrivX®from SSH Helsinki, Finland  SSH announced today that a major Governmental Entity in Europe, following an in-depth trial program, has selected PrivX® as their Privileged Access Management Solution. The customer is a new win for SSH. The annual deal value is EUR 0.9 million in subscription-based PrivX solution licenses for a large and highly connected systems environment. “I am extremely pleased that we won this deal with this significant Governmental Entity. This win highlights the strength of SSH PrivX and our novel approach to Privileged Access Management” said Dr. Teemu Tunkelo, CEO of SSH. “PrivX has already proven to be a very competitive and capable product in financial, manufacturing, and software-as-service markets. Now we are further strengthening our presence among...

First subject dosed with Nykode Therapeutics’ T cell focused SARS-CoV-2 vaccine candidate. This is part of the ongoing phase 1/2 two-arm clinical trial VB-D-01 designed to specifically address emerging variants of concern, including Omicron1 The T cell focused vaccine candidate (VB10.2210) encodes 96 clinically validated T cell epitopes spanning a total of eight SARS-CoV-2 proteins, including Spike. These Spike- and non-Spike T cell epitopes have been identified and validated by Adaptive Biotechnologies using their immune medicine platform Initial analysis indicates that no epitopes outside the Spike are affected by the Omicron variantOSLO, Norway, Dec. 28, 2021 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines...

CRIF – a global company specializing in credit bureau and business information, as well as advanced digital solutions for business development and open banking – announces the acquisition of ICAP – the largest B2B Services Group in Greece, with a strong presence also in Romania, Bulgaria and Cyprus. ICAP was established in 1964; in 2007 South Eastern Europe Fund, advised by Global Finance, acquired the majority stake with Coface, one of the world’s largest credit insurers and business information providers, and management participating in the acquisition. With 259 employees, ICAP currently serves local markets and global clients through a wide range of added value services and innovative solutions in the field of Credit Risk & Business Information Solutions. Moreover ICAP is the only company in Greece that has been...

GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2021 annual general meeting held today were duly passed. Specifically, the shareholders passed the following resolutions approving:the ratification of the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2021 and the authorization for the directors of the Company to determine the remuneration of the auditor; the re-election of Yusheng Han, Gang Lu and Shaokun Chuai as directors of the Company; the approval, confirmation and ratification of the adoption...